Antiatherogenic effect of Caps HT2, a herbal Ayurvedic medicine formulation

Medicine and Dentistry

• Hyperlipidemia 66%
• Lipoprotein Lipase 66%
• Hypolipemia 66%
• Anti-Inflammatory Drug 66%
• Cardiovascular System 33%
• Enzyme 33%
• Serositis 33%
• In Vitro 33%
• Body Weight 33%
• Antioxidant 33%
• Lipid Peroxidation 33%
• Combination Therapy 33%
• IC50 33%
• Superoxide 33%
• Obesity 33%
• High Density Lipoprotein Cholesterol 33%
• Heparin 33%
• Intravenous Drug Administration 33%
• Hydroxyl Radical 33%
• Formaldehyde 33%
• Adenosine Diphosphate 33%
• Platelet 33%
• Antithrombotic 33%
• Chronic Inflammation 33%
• Carrageenan 33%
• Thrombocyte Aggregation 33%
• Antiinflammatory Activity 33%
• Diet 33%
• Withania somnifera 33%
• Oral Drug Administration 33%
• Graphite 33%
• Medicine 33%
• Plasma 33%
• Atherogenesis 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Rat 100%
• Hyperlipidemia 66%
• Hypolipemia 66%
• Lipoprotein Lipase 66%
• Enzyme 33%
• IC50 33%
• Leporidae 33%
• Anticoagulant Agent 33%
• Obesity 33%
• Heparin 33%
• Inflammation 33%
• Antioxidant 33%
• High Density Lipoprotein Cholesterol 33%
• Adenosine Diphosphate 33%
• Superoxide 33%
• Hydroxyl Radical 33%
• Allium sativum 33%
• Carrageenan 33%
• Formaldehyde 33%
• Atherogenesis 33%
• Withania somnifera 33%
• Chronic Inflammation 33%
• Ocimum Tenuiflorum 33%
• Graphite 33%
• Plant 33%
• Tinospora cordifolia 33%
• Semecarpus anacardium 33%
• Commiphora 33%
• Terminalia arjuna 33%
• Hemidesmus indicus 33%